{
  "abstract": "BackgroundMultiple sclerosis (MS) is characterized by inflammatory activity and neurodegeneration; disease-modifying therapies incompletely address progression. Exercise is established for symptomatic benefit and has been proposed as an adjunct disease-modifying strategy, but review-level evidence is fragmented. Objective: To synthesize and appraise systematic-review evidence on structured exercise or physical activity for disease activity/progression, safety, and inflammatory/immune and neurobiomarker outcomes in adults with MS.MethodsThis umbrella review followed PRISMA 2020 and PRIOR; PubMed, Web of Science Core Collection, Embase, Cochrane Database of Systematic Reviews, Scopus, and SPORTDiscus were searched from inception to 8 October 2026. Eligible units were systematic reviews, meta-analyses, network meta-analyses, and dose-response meta-analyses. Two reviewers independently selected reviews, extracted data, and assessed methodological quality (AMSTAR 2), primary-study overlap (corrected covered area, CCA), and certainty (GRADE or CINeMA). Estimates were classified by estimand, and only comparisons of exercise with non-exercise comparators informed conclusions about intervention effects. Because biomarker clusters had high or very high overlap and source estimates were heterogeneous, no umbrella-level pooling was performed.ResultsTwenty-two reviews (2014–2026) were included. In trials reporting safety outcomes, no increased risk of relapse (RR 0.95, 95% CI 0.61–1.48) or serious adverse events (RR 1.05, 95% CI 0.62–1.80) was detected, although both intervals were wide, and any adverse event was more frequent but imprecise (RR 1.40, 95% CI 0.90–2.19). Against non-exercise controls, BDNF was higher after chronic training (SMD 0.78, 95% CI 0.27–1.28), and one meta-analysis reported lower TNF-α, interferon-γ, and interleukin-17. NfL decreased within exercise arms (SMD −0.55; not an intervention effect), and controlled trials were inconsistent (one small trial favorable, two larger trials null). No effect on relapse, EDSS (SMD 0.02, 95% CI −0.40 to 0.44), or MRI outcomes was shown; MSFC improved in three small trials (very low certainty). All reviews had low or critically low AMSTAR 2 confidence, and certainty was low for two outcomes and very low for 19.ConclusionCurrent review-level evidence does not indicate an increased risk of relapse or serious adverse events associated with exercise in adults with MS. Exercise may modulate selected biomarkers, but the available evidence does not demonstrate a disease-modifying effect.Systematic review registrationhttps://www.crd.york.ac.uk/PROSPERO/, identifier CRD420261410063.",
  "abstract_shown": true,
  "affiliations": [],
  "article_type": "Systematic Review",
  "arxiv": null,
  "author_total": 7,
  "authors": [
    {
      "name": "Jianmin Dai"
    },
    {
      "name": "Weibao Liang"
    },
    {
      "name": "Yufeng Kang"
    },
    {
      "name": "Mohan Sun"
    },
    {
      "name": "Jingwei Fang"
    },
    {
      "name": "Yue Zong"
    },
    {
      "name": "Leigang Song"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/1bq9zntxvsyyz.bib",
  "cited_by": 0,
  "doi": "10.3389/fimmu.2026.1933579",
  "fulltext_url": null,
  "id": "1bq9zntxvsyyz",
  "issns": [
    "1664-3224"
  ],
  "landing_url": "https://www.frontiersin.org/articles/10.3389/fimmu.2026.1933579",
  "language": null,
  "licence": "CC-BY-4.0",
  "licence_label": "CC BY 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "feed-journal",
      "biology/immunology"
    ]
  ],
  "openalex": null,
  "pdf_url": null,
  "pmcid": null,
  "pmid": null,
  "published": "2026-11-16",
  "publisher": "Frontiers Media SA",
  "ris": "https://research.draconitic.com/paper/1bq9zntxvsyyz.ris",
  "sources": [
    {
      "first_seen": "2026-11-16T06:20:32Z",
      "native_id": "10.3389/fimmu.2026.1933579",
      "source": "feed-frontiers",
      "url": "https://www.frontiersin.org/articles/10.3389/fimmu.2026.1933579"
    },
    {
      "first_seen": "2026-11-16T12:24:40Z",
      "native_id": "10.3389/fimmu.2026.1933579",
      "source": "crossref",
      "url": "https://www.frontiersin.org/articles/10.3389/fimmu.2026.1933579/full"
    }
  ],
  "subjects": [
    {
      "field": "biology",
      "origin": "feed-journal:biology/immunology",
      "subfield": "immunology"
    }
  ],
  "title": "Potential adjunct disease-modifying effects of exercise and physical activity in multiple sclerosis: an umbrella review of disease activity/progression, safety, and inflammatory-neurobiomarker evidence",
  "title_text": "Potential adjunct disease-modifying effects of exercise and physical activity in multiple sclerosis: an umbrella review of disease activity/progression, safety, and inflammatory-neurobiomarker evidence",
  "type": "peer-reviewed",
  "updated_at": "2026-11-16T12:24:40Z",
  "url": "https://research.draconitic.com/paper/1bq9zntxvsyyz",
  "venue": "Frontiers in Immunology",
  "versions": []
}